| Report Title | Price | Action |
|---|---|---|
| Cells Expressing C Type Lectin Domain Family 12 Member A (Myeloid Inhibitory C Type Lectin Like Receptor or Dendritic Cell Associated Lectin 2 or C Type Lectin Like Molecule 1 or CLEC12A) - Drugs in Development, 2021
Cells Expressing C Type Lectin Domain Family 12 Member A (Myeloid Inhibitory C Type Lectin Like Receptor or Dendritic Cell Associated Lectin 2 or C Ty...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Lipopolysaccharide (Endotoxin) - Drugs in Development, 2021
Lipopolysaccharide (Endotoxin) - Drugs in Development, 2021 Summary Lipopolysaccharide (Endotoxin) - Drugs in Development, 2021 provides in depth an...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Drugs in Development, 2021
Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCN...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Neonatal Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021
Neonatal Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021 Summary Neonatal Respiratory Distress Syndrome (Respiratory) - Dru...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Fibrosis (Musculoskeletal) - Drugs in Development, 2021
Fibrosis (Musculoskeletal) - Drugs in Development, 2021 Summary Fibrosis (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the ...
Published: Apr-2021 | No. of Pages: 250
|
$ 2500 | |
| Cells Expressing Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Drugs in Development, 2021
Cells Expressing Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Prostaglandin G/H Synthase (Cyclooxygenase or COX or PTGS or EC 1.14.99.1) - Drugs in Development, 2021
Prostaglandin G/H Synthase (Cyclooxygenase or COX or PTGS or EC 1.14.99.1) - Drugs in Development, 2021 Summary Prostaglandin G/H Synthase (Cyclooxy...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47) - Drugs in Development, 2021
Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47) - Drugs in Developme...
Published: Apr-2021 | No. of Pages: 125
|
$ 3000 | |
| Creutzfeldt Jakob Disease (Central Nervous System) - Drugs in Development, 2021
Creutzfeldt Jakob Disease (Central Nervous System) - Drugs in Development, 2021 Summary Creutzfeldt Jakob Disease (Central Nervous System) - Drugs i...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Follicular Lymphoma (Oncology) - Drugs in Development, 2021
Follicular Lymphoma (Oncology) - Drugs in Development, 2021 Summary Follicular Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview...
Published: Apr-2021 | No. of Pages: 375
|
$ 2500 | |
| Exo Alpha Sialidase (Neuraminidase or Acetylneuraminidase or EC 3.2.1.18) - Drugs in Development, 2021
Exo Alpha Sialidase (Neuraminidase or Acetylneuraminidase or EC 3.2.1.18) - Drugs in Development, 2021 Summary Exo Alpha Sialidase (Neuraminidase or...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Somatostatin Receptor Type 5 (SSTR5) - Drugs in Development, 2021
Somatostatin Receptor Type 5 (SSTR5) - Drugs in Development, 2021 Summary Somatostatin Receptor Type 5 (SSTR5) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Drugs in Development, 2021
Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Drugs in Development, 2021 Summary Mycobacterium t...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Musculoskeletal Pain (Central Nervous System) - Drugs in Development, 2021
Musculoskeletal Pain (Central Nervous System) - Drugs in Development, 2021 Summary Musculoskeletal Pain (Central Nervous System) - Drugs in Developm...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Follicular Thyroid Cancer (Oncology) - Drugs in Development, 2021
Follicular Thyroid Cancer (Oncology) - Drugs in Development, 2021 Summary Follicular Thyroid Cancer (Oncology) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Janus Kinase (JAK or EC 2.7.10.2) - Drugs in Development, 2021
Janus Kinase (JAK or EC 2.7.10.2) - Drugs in Development, 2021 Summary Janus Kinase (JAK or EC 2.7.10.2) - Drugs in Development, 2021 provides in de...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Adenosine Receptor A1 (ADORA1) - Drugs in Development, 2021
Adenosine Receptor A1 (ADORA1) - Drugs in Development, 2021 Summary Adenosine Receptor A1 (ADORA1) - Drugs in Development, 2021 provides in depth an...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Potassium Voltage Gated Channel Subfamily C Member 1 (Voltage Gated Potassium Channel Subunit Kv3.1 or Voltage Gated Potassium Channel Subunit Kv4 or KCNC1) - Drugs in Development, 2021
Potassium Voltage Gated Channel Subfamily C Member 1 (Voltage Gated Potassium Channel Subunit Kv3.1 or Voltage Gated Potassium Channel Subunit Kv4 or ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Uremic (Renal) Pruritus (Dermatology) - Drugs in Development, 2021
Uremic (Renal) Pruritus (Dermatology) - Drugs in Development, 2021 Summary Uremic (Renal) Pruritus (Dermatology) - Drugs in Development, 2021 provid...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Food Allergy (Immunology) - Drugs in Development, 2021
Food Allergy (Immunology) - Drugs in Development, 2021 Summary Food Allergy (Immunology) - Drugs in Development, 2021 provides an overview of the Fo...
Published: Apr-2021 | No. of Pages: 60
|
$ 2000 |